Press Releases

Current Articles | Categories | Search | Syndication

23 February 2012
Point-of-care cardiac testing improves patient care at Blackpool Victoria Hospital
By Rachel @ 16:02 :: 59 Views

The A&E Department at Blackpool Victoria Hospital is taking advantage of the point-of-care immunoassay capabilities of Radiometer’s AQT90 FLEX analyser to assess patients with low risk chest pain, helping to speed up diagnosis and reduce the need for unnecessary admissions. 

Read More

10 February 2012
Experts meet to explore the Value of Pathology ahead of the National Pathology Year 2012
By Rachel @ 17:07 :: 65 Views

Roche sponsors prestigious pathology event and world premiere of a new educational film – ‘The Ultimate Goal’

Read More

18 January 2012
Thermo Fisher Scientific Introduces New Improved Universal Containers
By Rachel @ 11:35 :: 102 Views

Sterilin 30mL Universals with quick start cap and improved leak-free performance

NEWPORT, Wales (January 18, 2012) – Thermo Fisher Scientific, the world leader in serving science, today introduced a range of new, improved Thermo Scientific Sterilin 30mL Universal Containers with easier handling and improved leak-free performance. 

Read More

17 January 2012
E-learning package helps York Teaching Hospital meet CPA standards for Point of Care Testing
By Rachel @ 11:17 :: 90 Views

Roche solution saves time and provides consistent, high standard of training which ultimately enhances patient safety

As Point of Care (POC) diagnostic testing increases in healthcare facilities, the training of users to ensure that they are competent in using POCT equipment is becoming an ever growing challenge.This has been recognised in the Clinical Pathology Accreditation (CPA) standards for POC testing, which calls for POC testing facilities to demonstrate adequate training and recertification of operators. York Hospital has adopted the cobas® academy e-learning tool from Roche to help meet these requirements.

Read More

17 January 2012
Highly specific Lp(a) assay from Randox available for chemistry analysers
By Rachel @ 11:13 :: 66 Views

The Randox liquid ready to use Lipoprotein (a) assay provides a highly sensitive and specific method for the detection of Lp(a) in human serum and plasma.  The assay is based on an immunoturbidimetric method and is suitable for use on most chemistry analysers, the assay is not affected by Apo(a) size related bias like other commercially available methods.  

Read More

13 January 2012
Radiometer’s QA Portal helps Royal Hampshire meet EQA requirements
By Rachel @ 11:03 :: 88 Views

The Royal Hampshire County Hospital (RHCH), Winchester, has six Radiometer blood gas analysers – including 810, 820, 825M and 835M systems – and relies on the Company’s QA Portal to help meet EQA requirements and simplify regulatory compliance. Colin Dickens, Manager of the Biochemistry Department at RHCH, explained: “All the blood gas analysers are connected using the RADIANCE system, which provides 24 hour monitoring to ensure our instruments are operating correctly and, as part of our quality assurance, we also use Radiometer’s QA Portal to monitor the alignment of the instruments.”

Read More

21 December 2011
Point of care testing: Roche helps Stepping Hill Hospital to meet vital data management and audit requirements
By Rachel @ 16:53 :: 106 Views

Stockport NHS Foundation Trust among first to achieve CPA accreditation for point of care testing (POCT)

Roche cobas® IT1000 POCT Data Manager helps Stepping Hill Hospital to meet vital data management and audit requirements

Read More

20 December 2011
Liquid ready to use Cystatin C assay from Randox provides a more sensitive marker of GFR compared to Creatinine
By Rachel @ 16:49 :: 97 Views

The liquid ready to use Cystatin C assay from Randox provides a good indicator of Glomerular Filtration Rate (GRF). As a more sensitive maker of renal dysfunction, Cystatin C offers several advantages over traditional creatinine assays.

Read More

06 December 2011
New molecular diagnostic test from Randox enables rapid, appropriate selection of Colorectal cancer patients for anti-EGFR therapy.
By Rachel @ 17:01 :: 131 Views

Colorectal Cancer (CRC) is the third most common cancer worldwide1. Metastatic disease accounts for 40-50% of newly diagnosed patients and is associated with high morbidity 1,2. Despite recent therapeutic advances, the prognosis for metastatic CRC (mCRC) remains poor. Early diagnosis and assignment of the most appropriate therapy pathway is therefore crucial. The KRAS/BRAF/PIK3CA Array from Randox allows the clinician to select appropriate patients for anti-EGFR therapy, maximising drug efficacy and minimising adverse side effects to the patient. 

Read More

01 December 2011
St James Hospital, Dublin reaps time and workload benefits from a fully connected point of care solution
By Rachel @ 12:28 :: 123 Views

Roche total solution ensures smooth delivery, management and monitoring of blood glucose and blood gas testing

Point of care (POC) blood glucose and blood gas testing at St James Hospital, Dublin is managed centrally through the Roche cobas® IT 1000 point of care data management software. This has allowed significant time savings and more efficient workload management, and has helped the hospital to meet accreditation requirements for POC testing.

Read More

Previous Page | Next Page